Open- | Close- |
Vol / Avg.22.000 / 193.469K | Mkt Cap100.358M |
Day Range- - - | 52 Wk Range1.300 - 11.980 |
Omega Therapeutics Stock (NASDAQ: OMGA) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.22.000 / 193.469K | Mkt Cap100.358M |
Day Range- - - | 52 Wk Range1.300 - 11.980 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.530 | -0.400 | 0.1300 | ||||
REV | 440.000K | 831.000K | 391.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-13 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Raises | 11.00 | 12.00 |
2023-11-10 | Wedbush | Robert Driscoll | Maintains | OutperformOutperform | Lowers | 19.00 | 12.00 |
2023-09-01 | HC Wainwright & Co. | Robert Burns | Reiterates | BuyBuy | Maintains | - | 11.00 |
2023-08-04 | Chardan Capital | Keay Nakae | Reiterates | BuyBuy | Maintains | - | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OMGA | Omega Therapeutics | 0% | 100.4M |
ANIX | Anixa Biosciences | -5.69% | 97.9M |
CARM | CARISMA Therapeutics | 1.06% | 96.5M |
BNR | Burning Rock Biotech | 1.53% | 92.5M |
EGRX | Eagle Pharmaceuticals | 0% | 106.9M |
You can purchase shares of Omega Therapeutics (NASDAQ: OMGA) through any online brokerage.
Other companies in Omega Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR), Eagle Pharmaceuticals (NASDAQ:EGRX) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Omega Therapeutics (NASDAQ: OMGA) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 12.00 expecting OMGA to rise to within 12 months (a possible 559.34% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Omega Therapeutics (NASDAQ: OMGA) is $1.82 last updated November 28, 2023 at 9:02 PM UTC.
There is no dividend information for Omega Therapeutics.
Omega Therapeutics’s Q4 earnings are confirmed for Wednesday, February 28, 2024.
There is no upcoming split for Omega Therapeutics.
Omega Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.